There are three molecular classes of breast cancer: hormone receptor positive/ERBB2 (receptor tyrosine-protein kinase)-negative (HR+/ERBB2−), ERBB2 positive (ERBB2+), and triple-negative (3). This evidence concerns the gene ERBB2 and breast cancer.